These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26563443)

  • 1. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
    Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
    Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
    Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
    PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.
    Sato T; Seyama K; Kumasaka T; Fujii H; Setoguchi Y; Shirai T; Tomino Y; Hino O; Fukuchi Y
    J Intern Med; 2004 Aug; 256(2):166-73. PubMed ID: 15257730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
    Carsillo T; Astrinidis A; Henske EP
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6085-90. PubMed ID: 10823953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
    Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
    Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.
    Cai X; Pacheco-Rodriguez G; Fan QY; Haughey M; Samsel L; El-Chemaly S; Wu HP; McCoy JP; Steagall WK; Lin JP; Darling TN; Moss J
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1410-8. PubMed ID: 20639436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
    Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
    Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.
    Muzykewicz DA; Sharma A; Muse V; Numis AL; Rajagopal J; Thiele EA
    J Med Genet; 2009 Jul; 46(7):465-8. PubMed ID: 19419980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
    Yu J; Astrinidis A; Henske EP
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
    Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
    Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story.
    Murphy SJ; Terra SB; Harris FR; Nasir A; Voss JS; Smadbeck JB; Johnson SH; Serla V; Ryu JH; Yi ES; Kipp BR; Vasmatzis G; Carmona EM
    Mod Pathol; 2017 Sep; 30(9):1223-1233. PubMed ID: 28643793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A second hit somatic (p.R905W) and a novel germline intron-mutation of TSC2 gene is found in intestinal lymphangioleiomyomatosis: a case report with literature review.
    Han B; Lee J; Kwak YJ; Kim HY; Lee KH; Shim Y; Lee H; Park SH
    Diagn Pathol; 2021 Aug; 16(1):83. PubMed ID: 34465349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM).
    Liu J; Zhao W; Ou X; Zhao Z; Hu C; Sun M; Liu F; Deng J; Gu W; An J; Zhang Q; Zhang X; Xie J; Li S; Chen R; Yu S; Zhong N
    PLoS One; 2019; 14(12):e0226400. PubMed ID: 31856217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.
    Goncharova EA; Krymskaya VP
    J Cell Biochem; 2008 Feb; 103(2):369-82. PubMed ID: 17541983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular insights into lymphangioleiomyomatosis.
    Steagall WK; Taveira-DaSilva AM; Moss J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.